MeDiNova has a large, world-wide patient population reach with 106 sites based around the globe in the UK, South Africa, Spain, USA, Poland, Romania, The Netherlands, Russia and Bulgaria.
There are currently 8 sites within the UK, 33 sites across South Africa, 3 sites in Spain, 33 sites located across the USA, 10 sites in Poland, 7 sites in Romania, 1 site in The Netherlands, 9 sites in Russia and 1 site in Bulgaria.
MeDiNova has a significant number of patients who participate in our clinical trials. We use an innovative range of approaches to recruit patients including:
- Direct recruitment through social media, radio, magazine and newspaper advertising.
- GPs, Physicians and Consultants within Healthcare organisations
- Patient organisations
GPs also appreciate this collaborative approach. We frequently
undertake Disease Awareness sessions that are well attended by patients and GPs who find them very informative.
MeDiNova has been very successful in recruiting and retaining patients for clinical trials across a broad spectrum of therapeutic areas.